Back to Companies
Nuvectis Pharma, Inc.
NVCTNasdaqCIK: 0001875558
Recent Form 4 activity at Nuvectis Pharma, Inc. (NVCT) spans 13 filings across 7 insiders (all of them on the buy side). Purchases total $2.3M against $0 in sales — heavily weighted toward buying, for a net purchase of $2.3M. Mosseri Marlio Charles (10% Owner) is the most active by dollar volume, and the single largest transaction was $957.1K by Mosseri Marlio Charles. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.
Total Volume
$2.3M
Purchases
$2.3M
Sales
$0
Unique Insiders
7
Recent Insider Trades
13 loaded
| Aug 5 | NVCT Nuvectis Pharma, Inc. | Carson Michael J. | Vice President, Finance | Grant | $0 |
| Jul 1 | NVCT Nuvectis Pharma, Inc. | BENTSUR RON | Chairman & CEO, Director, 10% Owner | Buy | $250.0K |
| Jul 1 | NVCT Nuvectis Pharma, Inc. | Mosseri Marlio Charles | 10% Owner | Buy | $916.0K |
| Jun 12 | NVCT Nuvectis Pharma, Inc. | Sanchez Juan | Director | Grant | $0 |
| Jun 12 | NVCT Nuvectis Pharma, Inc. | Kaplan Matthew L. | Director | Grant | $0 |
| Jun 12 | NVCT Nuvectis Pharma, Inc. | Hoberman Kenneth | Director | Grant | $0 |
| Jun 12 | NVCT Nuvectis Pharma, Inc. | Oliviero James F III | Director | Grant | $0 |
| Nov 6 | NVCT Nuvectis Pharma, Inc. | BENTSUR RON | Chairman & CEO, Director, 10% Owner | Buy | $28.6K |
| Nov 6 | NVCT Nuvectis Pharma, Inc. | Sanchez Juan | Director | Buy | $75.3K |
| Nov 6 | NVCT Nuvectis Pharma, Inc. | Kaplan Matthew L. | Director | Buy | $64.2K |
| Oct 29 | NVCT Nuvectis Pharma, Inc. | Mosseri Marlio Charles | 10% Owner | Buy | $957.1K |
| Oct 31 | NVCT Nuvectis Pharma, Inc. | Sanchez Juan | Director | Other | $0 |
| Oct 31 | NVCT Nuvectis Pharma, Inc. | Sanchez Juan | Director | Grant | $0 |
13 filings